Show simple item record

dc.contributor.authorKeilholz, U.
dc.contributor.authorAscierto, P. A.
dc.contributor.authorDummer, R.
dc.contributor.authorRobert, C.
dc.contributor.authorLorigan, Paul C
dc.contributor.authorvan Akkooi, A.
dc.contributor.authorArance, A.
dc.contributor.authorBlank, C. U.
dc.contributor.authorSileni, V. C.
dc.contributor.authorDonia, M.
dc.contributor.authorFaries, M. B.
dc.contributor.authorGaudy-Marqueste, C.
dc.contributor.authorGogas, H.
dc.contributor.authorGrob, J. J.
dc.contributor.authorGuckenberger, M.
dc.contributor.authorHaanen, J.
dc.contributor.authorHayes, A. J.
dc.contributor.authorHoeller, C.
dc.contributor.authorLebb�, C.
dc.contributor.authorLugowska, I.
dc.contributor.authorMandal�, M.
dc.contributor.authorMarquez-Rodas, I
dc.contributor.authorNathan, P.
dc.contributor.authorNeyns, B.
dc.contributor.authorBagge, R. O.
dc.contributor.authorPuig, S.
dc.contributor.authorRutkowski, P.
dc.contributor.authorSchilling, B.
dc.contributor.authorSondak, V. K.
dc.contributor.authorTawbi, H.
dc.contributor.authorTestori, A.
dc.contributor.authorMichielin, O.
dc.date.accessioned2020-09-16T11:57:56Z
dc.date.available2020-09-16T11:57:56Z
dc.date.issued2020en
dc.identifier.citationKeilholz U, Ascierto PA, Dummer R, Robert C, Lorigan P, van Akkooi A, et al. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Annals of Oncology. 2020.en
dc.identifier.pmid32763453en
dc.identifier.doi10.1016/j.annonc.2020.07.004en
dc.identifier.urihttp://hdl.handle.net/10541/623253
dc.description.abstractThe European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO Clinical Practice Guideline and where available evidence is either limited or conflicting. The main topics identified for discussion were (i) the management of locoregional disease; (ii) targeted versus immunotherapies in the adjuvant setting; (iii) targeted versus immunotherapies for the first-line treatment of metastatic melanoma; (iv) when to stop immunotherapy or targeted therapy in the metastatic setting; and (v) systemic versus local treatment for brain metastases. The expert panel was divided into five working groups to each address questions relating to one of the five topics outlined above. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel for further discussion and amendment before voting. This manuscript presents the results relating to the management of metastatic melanoma, including findings from the expert panel discussions, consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.annonc.2020.07.004en
dc.titleESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines Committeeen
dc.typeArticleen
dc.contributor.departmentCharit� Comprehensive Cancer Center, Charit�-Universit�tsmedizin Berlin, Berlin, Germanyen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]
refterms.dateFOA2020-09-16T14:33:43Z


Files in this item

Thumbnail
Name:
ESMOKeilholz.pdf
Size:
562.5Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record